Best practices in the laboratory diagnosis, prognostication, prediction, and monitoring of Graves’ disease: role of TRAbs
Abstract Graves' disease (GD) is an autoimmune disorder characterized by activation of the TSH receptor by stimulatory autoantibodies (TSH Receptor Antibodies, or TRAbs), leading to unregulated thyroid hormone production. Diagnosis is largely based on the typical clinical picture and laboratory...
Saved in:
| Main Authors: | Sanjay Kalra, Shahjada Selim, Dina Shrestha, Noel Somasundaram, Syed Abbas Raza, Manash P. Baruah, Saptarshi Bhattacharya, Sharvil Gadve, Ganapathi Bantwal, Rakesh Sahay |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-12-01
|
| Series: | BMC Endocrine Disorders |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12902-024-01809-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neonatal Graves’ disease from high maternal TRAB antibody levels despite definitive therapy
by: Dalal S. Ali, et al.
Published: (2025-06-01) -
Impact of serum TRAb level changes on the efficacy of 131I therapy in Graves’ disease: a decision tree prediction model
by: Ziyu Ma, et al.
Published: (2025-07-01) -
Combining biomarkers to predict the disease activity of graves’ ophthalmopathy: a combinatory model of the NLR, TRAb and FT4
by: Tongxin Niu, et al.
Published: (2025-06-01) -
Clinical utility of TSH receptor antibody levels in Graves’ orbitopathy: a comparison of two TSH receptor antibody immunoassays
by: Gabriela A. Bluszcz, et al.
Published: (2018-12-01) -
The prognosis of severe subclinical hyperthyroidism with TSH below 0.1 μU/mL due to Graves’ disease in the Japanese population
by: Yui Nishijima, et al.
Published: (2025-06-01)